GAMIFANT

LIVE

Serial Number

87283834

Owner

NovImmune SA

Attorney

Brendan J. Hughes

Filing Date

Dec 29, 2016

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

GAMIFANT Trademark

Serial Number: 87283834 • Registration: 5505933

GAMIFANT is a trademark filed by NovImmune SA on December 29, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 1 - Chemicals

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

NovImmune SA (6 trademarks)

15ch. Du Pré Fleuri, Plan les Ouates
Geneva 1228 , CH

Entity Type: 03

SWEDISH ORPHAN BIOVITRUM AG

12 CH. DES AULX
PLAN-LES-OUATES, GENEVA 1228 , CH

Entity Type: 03

EMACO SA

14 CH. DES AULS
GENEVA , CH

Entity Type: 03

Legal Representation

Attorney of Record

Brendan J. Hughes

2,674 trademarks filed View all →

Trademark Details

Filing Date

December 29, 2016

Registration Date

July 3, 2018

Published for Opposition

April 17, 2018

Goods & Services

Pharmaceutical and biological preparations to treat immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; pharmaceutical and biological preparations based on polypeptides, superantigens, biomarkers and antibodies to treat immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; Pharmaceutical and biological preparations and immunotherapies being medical preparations for stimulating the immune response, all for use in the diagnosis, prevention, management and treatment of immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; therapeutic and diagnostic agents, preparations and substances for medical purpose for use in therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; biochemical substance, polypeptides, antibodies, biomarkers and superantigens for use in diagnoses and therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; engineered cell therapies, namely engineered T cells, immune cells, and antibodies for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic test kits consisting primarily of biomarkers for medical purposes; biochemical test kits comprised of assays and reagents for medical, diagnostic and therapeutic purposes

Biochemicals, namely, polypeptides, superantigens, biomarkers and antibodies for medical and scientific research; cells, cell extracts and components of cells for medical and scientific research; diagnostic agents for medical and scientific research; diagnostic biomarker reagent for biomarker reagents for medical and scientific research; diagnostic test kits consisting primarily of biomarkers for medical and scientific research; biochemical test kits consisting of assays and reagents for medical and scientific research purposes

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Oct 18, 2023 TCCA

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Oct 18, 2023 ECDR

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Oct 18, 2023 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Oct 18, 2023 REAP

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Oct 18, 2023 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Oct 18, 2023 COAR

TEAS SECTION 8 & 15 RECEIVED

Aug 30, 2023 E815

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jul 3, 2023 REM1

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Apr 20, 2023 CHAN

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 20, 2023 TCCA

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Apr 20, 2023 ECDR

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Apr 20, 2023 EWAF

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 20, 2023 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 20, 2023 REAP

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Apr 20, 2023 COAR

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jan 25, 2023 ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jul 17, 2019 ASGN

REGISTERED-PRINCIPAL REGISTER

Jul 3, 2018 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 17, 2018 NPUB

PUBLISHED FOR OPPOSITION

Apr 17, 2018 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 28, 2018 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 13, 2018 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 13, 2018 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 12, 2018 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 12, 2018 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 2, 2017 GNRN

NON-FINAL ACTION E-MAILED

Nov 2, 2017 GNRT

NON-FINAL ACTION WRITTEN

Nov 2, 2017 CNRT

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 12, 2017 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 12, 2017 CRFA

ASSIGNED TO LIE

Oct 10, 2017 ALIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 27, 2017 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 27, 2017 GNRN

NON-FINAL ACTION E-MAILED

Mar 27, 2017 GNRT

NON-FINAL ACTION WRITTEN

Mar 27, 2017 CNRT

ASSIGNED TO EXAMINER

Mar 27, 2017 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 10, 2017 NWOS

NEW APPLICATION ENTERED

Jan 2, 2017 NWAP

Related Trademarks

More from this Owner

LIGHTCHAIN BIOSCIENCE

LIGHTCHAINBIO

K BODY

LIGHTCHAIN BIOSCIENCE

GAMHALTY

More in Same Class